Z. Upton et al., PRODUCTION AND CHARACTERIZATION OF RECOMBINANT CHICKEN INSULIN-LIKE GROWTH FACTOR-II FROM ESCHERICHIA-COLI, Journal of molecular endocrinology, 14(1), 1995, pp. 79-90
Recombinant chicken (c)IGF-II has been produced in Escherichia coli af
ter first modifying a plasmid that coded for a human (h)IGF-II fusion
protein. The cIGF-II fusion protein, deposited in bacterial inclusion
bodies, was dissolved under reducing conditions, desalted, subjected t
o anion-exchange chromatography and refolded. Recombinant cIGF-II was
then released from the fusion protein using a genetically engineered s
erine protease and purified to homogeneity by reverse-phase HPLC. In v
itro analysis of recombinant cIGF-II revealed differences between cIGF
-II and its human counterpart. Recombinant cIGF-II was less potent tha
n hIGF-II in stimulating protein synthesis in rat myoblasts. This appe
ared to be due to a decreased affinity far the type-1 IGF receptor. Th
e human and chicken peptides were similar, however, in studies assessi
ng binding to the type-2 IGF receptor and to IGF-binding proteins. Mor
eover, recombinant cIGF-II and hIGF-II were equipotent in both biologi
cal and receptor binding studies in chick embryo fibroblasts, suggesti
ng that there may be a difference between mammalian and avian type-1 I
GF receptors.